Collagen membrane arranged at macromolecular level
WO0102386A1
SELECTIVE M2 MUSCARINIC RECEPTOR ANTAGONISTS HAVING 5H-DIBENZ[b,f]AZEPINE STRUCTURE
BR9916053A
Compositions containing a peptide and a polylactic glycolic acid, suitable for the preparation of subcutaneous implants with a prolonged release period
EP0772608A1
Phenylcarbamate derivatives suitable to the use as anticholinesterase substances
CA2151610A1
Oligosaccharides having biological activity and preparation of same from glycosaminoglycans
ITMI932219D0
Pharmaceutical compositions containing an active phosphatidyl inositol substance suitable for the treatment of peripheral neural diseases due to diabetes mellitus
EP0575954A1
Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process
EP0537634A2
Iron complexes containing conalbumin and its derivatives
EP0531958A1
6-Aminoquinolones, their synthesis and their use as antibacterial agents
ITMI921770A1
Pharmaceutical compositions suitable for the treatment of memory disturbances
US5463012A
Polycarbonates and the use thereof for the preparation of bioerosible matrices
EP0522277A1
Process for the preparation of 9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acid hydrochloride
US5352810A
Phosphatidylinositol analogues, inhibitors of phosphatidylinositol specific phospholipase C
US5214180A
Highly pure phosphatidylinositol of natural source useful for the treatment of central nervous system disorders and process for its preparation
EP0492383A1
Use of heptastigmine in the therapy of cerebral ictus
EP0486958A1
Physostigmine derivatives
US5352703A
Antitussive and mucus regulating agent, a process for the preparation thereof and pharmaceutical compositions containing it
EP0450508A2
Use of dermatan sulphate for the prevention and therapy of cerebral aging and of central nervous system functional deficit states
